Table 3. Comparison of treatment outcomes among children with newly diagnosed TB, stratified by disease classification and treatment strategy, registered in Gujarat State, India, June-September 2012.
Characteristics | Treatment Strategy | P-value | |||
---|---|---|---|---|---|
Family DOT (Intervention district) | Non-Family DOT (Usual-practice districts) | ||||
Number | % | Number | % | ||
All TB patients | 359 | 100 | 265 | 100 | |
Cured | 47 | 13.1 | 35 | 13.2 | 0.17 |
Treatment completed | 297 | 82.7 | 212 | 80.0 | |
Death | 5 | 1.4 | 6 | 2.3 | |
Default | 4 | 1.1 | 10 | 3.8 | |
Transfer Out | 3 | 0.8 | 2 | 0.8 | |
Failure | 3 | 0.8 | 0 | 0.0 | |
New smear-positive PTB | 58 | 100 | 43 | 100 | |
Cured | 47 | 81.0 | 35 | 81.4 | 0.22 |
Treatment completed | 2 | 3.4 | 4 | 9.3 | |
Death | 3 | 5.2 | 3 | 7.0 | |
Default | 3 | 5.2 | 0 | 0.0 | |
Transfer Out | 0 | 0.0 | 1 | 2.3 | |
Failure | 3 | 5.2 | 0 | 0.0 | |
New smear-negative PTB | 28 | 100 | 34 | 100 | |
Treatment completed | 28 | 100.0 | 33 | 97.1 | 1.0 |
Death | 0 | 0.0 | 1 | 2.9 | |
Default | 0 | 0.0 | 0 | 0.0 | |
Transfer Out | 0 | 0.0 | 0 | 0.0 | |
Failure | 0 | 0.0 | 0 | 0.0 | |
New others a | 77 | 100 | 45 | 100 | |
Treatment completed | 76 | 98.7 | 42 | 93.3 | 0.05 |
Death | 1 | 1.3 | 0 | 0.0 | |
Default | 0 | 0.0 | 3 | 6.7 | |
Transfer Out | 0 | 0.0 | 0 | 0.0 | |
Failure | 0 | 0.0 | 0 | 0.0 | |
New extra-pulmonary TB | 196 | 100 | 143 | 100 | |
Treatment completed | 191 | 97.5 | 133 | 93.0 | 0.02 |
Death | 1 | 0.5 | 2 | 1.4 | |
Default | 1 | 0.5 | 7 | 4.9 | |
Transfer Out | 3 | 1.5 | 1 | 0.7 | |
Failure | 0 | 0.0 | 0 | 0.0 |
a A patient who does not fit into the any of the types mentioned above (smear positive, smear negative, extra pulmonary), where bacteriological evidence could not be demonstrated but decision to treat was taken on clinical grounds would continue to be recorded and reported as “OTHERS”.
Note: Fischer’s exact test was used for assessing difference between the proportions as the expected cell values is many of the cells were less than 5.